White label – Pompe disease - ClinicalTrials.eu

Study on Preventing Respiratory Infections in Elderly Patients Using OM85

Recruiting

3 1 1
Investigated Diseases:
- Respiratory tract infection
Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

Recruiting

3 1 1 1
Investigated Drugs:
Title: Comparing tebentafusp treatment versus observation in patients with high-risk eye melanoma (uveal melanoma) after initial treatment

Recruiting

3 1 1 1
Investigated Drugs:
- Tebentafusp
+3
Study of Durvalumab, Tremelimumab, Chemotherapy, and Radiotherapy for Patients with Newly Diagnosed Non-Small Cell Lung Cancer with Limited Spread

Recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
- Non-small cell lung cancer
Investigated Drugs:
- Tremelimumab
- Durvalumab
Study on the Effectiveness and Safety of Navepegritide for Adolescents with Achondroplasia

Recruiting

2 1
Study of Temozolomide and Lomustine Followed by Radiotherapy versus Standard Treatment in Patients with Newly Diagnosed Grade 2 or 3 Glioma

Recruiting

3 1 1 1
Investigated Diseases:
- Glioma
Investigated Drugs:
Study comparing BCG and combination of BCG with electromotive mitomycin-C treatment in patients with high-risk non-muscle-invasive bladder cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
- Mitomycin
Comparing Buprenorphine/Naloxone and Methadone for Opioid Use Disorder in Patients with Chronic Pain: A Study on Reducing Opioid Misuse

Recruiting

3 1 1 1
Investigated Diseases:
- Drug use disorder
- Pain
Investigated Drugs:
Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

Recruiting

1 1 1
Investigated Diseases:
- Acute lymphocytic leukaemia recurrent
- Non-Hodgkin’s lymphoma refractory
Investigated Drugs:
- T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn’s disease or ulcerative colitis

Recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated Drugs:
- Adalimumab
- Infliximab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies